Selective IgA deficiency associated with three organspecific autoimmune diseases, anti-IgA antibodies and erythrocyte-binding IgA

1987 ◽  
Vol 10 (3) ◽  
pp. 309-317
Author(s):  
Yukinobu Ichikawa ◽  
Mitsuaki Uchiyama ◽  
Shigeru Arimori ◽  
Junichi Ogawa ◽  
Hiroshi Inoue ◽  
...  
2019 ◽  
Vol 11 (4) ◽  
pp. 181-182
Author(s):  
Silvia Muriño

Selective IgA deficiency is the most common primary immunodeficiency. A small percentage presents pathology, but at older age can associate deficiency of some subclass of IgG and greater susceptibility to infections, allergic diseases, autoimmune diseases and neoplasms.


1991 ◽  
Vol 58 (1) ◽  
pp. 92-101 ◽  
Author(s):  
P.C.J. de Laat ◽  
C.M.R. Weemes ◽  
J.A.J.M. Bakkeren ◽  
F.C.A. van den Brandt ◽  
T.G.P.M. van Lith ◽  
...  

2010 ◽  
Vol 30 (6) ◽  
pp. 872-880 ◽  
Author(s):  
Ana Elisa Fusaro ◽  
Kristine Fahl ◽  
Elaine Cristina Cardoso ◽  
Cyro Alves de Brito ◽  
Cristina M. A. Jacob ◽  
...  

Author(s):  
Isabella Quinti ◽  
Eva Piano Mortari ◽  
Ane Fernandez Salinas ◽  
Cinzia Milito ◽  
Rita Carsetti

A large repertoire of IgA is produced by B lymphocytes with T-independent and T-dependent mechanisms useful in defense against pathogenic microorganisms and to reduce immune activation. IgA is active against several pathogens, including rotavirus, poliovirus, influenza virus, and SARS-CoV-2. It protects the epithelial barriers from pathogens and modulates excessive immune responses in inflammatory diseases. An early SARS-CoV-2 specific humoral response is dominated by IgA antibodies responses greatly contributing to virus neutralization. The lack of anti-SARS-Cov-2 IgA and secretory IgA (sIgA) might represent a possible cause of COVID-19 severity, vaccine failure, and possible cause of prolonged viral shedding in patients with Primary Antibody Deficiencies, including patients with Selective IgA Deficiency. Differently from other primary antibody deficiency entities, Selective IgA Deficiency occurs in the vast majority of patients as an asymptomatic condition, and it is often an unrecognized, Studies are needed to clarify the open questions raised by possible consequences of a lack of an IgA response to SARS-CoV-2.


1986 ◽  
Vol 9 (6) ◽  
pp. 507-513
Author(s):  
Naomi Wakasugi ◽  
Takayoshi Satoh ◽  
Naohiro Ozawa ◽  
Masaru Shimizu ◽  
Shigehiko Kamoshita

1988 ◽  
Vol 47 (2) ◽  
pp. 199-207 ◽  
Author(s):  
Antonio Ferreira ◽  
Maria Cruz Garcia Rodriguez ◽  
Margarita Lopez-Trascasa ◽  
Dora Pascual Salcedo ◽  
Gumersindo Fontan

2021 ◽  
Vol 19 (1) ◽  
pp. 12-23
Author(s):  
Ceyda TUNAKAN DALGIÇ ◽  
Aytül Zerrin Sin ◽  
Fatma Ömür Ardeniz

ABSTRACT Objective: Primary immunodeficiencies (PIDs) consist of genetically heterogeneous disorders. The spectrum can include infectious diseases, malignancy, allergy, and autoimmunity. We aimed to analyze the frequency and variety of autoimmune diseases (ADs) in PIDs and describe their clinical and laboratory features. Materials and Methods: Ninety-two patients with PID followed by Ege University Medical Faculty between 2000 and 2017 were enrolled in this retrospective, cross-sectional study. All patients’ medical records were reviewed using the demographic information, type of PIDs and ADs, ADs-related autoantibodies, and basic and immunologic laboratory findings. ADs were diagnosed using clinical and complementary paraclinical findings by an immunologist and/or a subspecialist related to the affected organ or system. Results: We evaluated 50 male and 42 female PID patients with a mean age of 40.92 (18-86). Twenty-nine (32 %) patients (15 females/14 males) with a mean age of 43.8 (19-78) had ADs. In our study group, the most commonly detected type of PID with AD is common variable immune deficiency (CVID) (n=17); followed by combined immune deficiency (CID) (n=3), CTLA4 deficiency (n=2), selective IgA deficiency (sIgAD) (n=2), specific IgG subgroup deficiency (n=1), autoimmune polyglandular syndrome (APS) with hypogammaglobulinemia (n=1), dyskeratosis congenita (DC) (n=1), Osler-Rendu-Weber (ORW) syndrome with CVID-like PID (n=1), and cartilage-hair hypoplasia (CHH) (n=1). According to systematic assessments, ADs resulted in endocrinologic 14%, dermatologic 10.8%, rheumatologic 9.7%, gastroenterological 9.7%, hematological 8.6%, and neurologic disorders 1%. The frequency of ADs was higher in CVID cases than other types of PIDs (p <0.05). Basic and immunologic laboratory findings of the PIDs with and without ADs were analyzed and compared; however, no statical significant difference was obtained between the groups. Conclusion: We have analyzed the frequency and variety of ADs in a adult PID cohort in Turkey. Patients presenting with multiple ADs should be screened for having an underlying PID. Keywords: Primary immune deficiency, autoimmunity, autoantibody, immunologic parameters, frequency


2011 ◽  
Vol 17 (11-12) ◽  
pp. 1383-1396 ◽  
Author(s):  
Ning Wang ◽  
Nan Shen ◽  
Timothy J. Vyse ◽  
Vidya Anand ◽  
Iva Gunnarson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document